Ghrelin and Insulin Resistance
NCT00884494
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Insulin Resistance
Normal Weight,Healthy Controls
Interventions
DRUG:
Ghrelin infusion to assess effects on insulin sensitivity
Sponsor
Vanderbilt University Medical Center